HomeCompareISR vs NOBL

ISR vs NOBL: Dividend Comparison 2026

ISR yields 520.83% · NOBL yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ISR wins by $316.8K in total portfolio value
10 years
ISR
ISR
● Live price
520.83%
Share price
$0.38
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$339.6K
Annual income
$875.92
Full ISR calculator →
NOBL
NOBL
● Live price
2.14%
Share price
$106.01
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.8K
Annual income
$246.19
Full NOBL calculator →

Portfolio growth — ISR vs NOBL

📍 ISR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodISRNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ISR + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ISR pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ISR
Annual income on $10K today (after 15% tax)
$44,270.83/yr
After 10yr DRIP, annual income (after tax)
$744.53/yr
NOBL
Annual income on $10K today (after 15% tax)
$182.19/yr
After 10yr DRIP, annual income (after tax)
$209.26/yr
At 15% tax rate, ISR beats the other by $535.27/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ISR + NOBL for your $10,000?

ISR: 50%NOBL: 50%
100% NOBL50/50100% ISR
Portfolio after 10yr
$181.2K
Annual income
$561.05/yr
Blended yield
0.31%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ISR right now

ISR
Analyst Ratings
5
Buy
1
Hold
Consensus: Buy
NOBL
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ISR buys
0
NOBL buys
0
No recent congressional trades found for ISR or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricISRNOBL
Forward yield520.83%2.14%
Annual dividend / share$2.00$2.27
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%0%
Portfolio after 10y$339.6K$22.8K
Annual income after 10y$875.92$246.19
Total dividends collected$203.5K$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: ISR vs NOBL ($10,000, DRIP)

YearISR PortfolioISR Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$36,742$26,041.67$10,914$214.34+$25.8KISR
2$84,025$44,710.95$11,897$218.63+$72.1KISR
3$137,686$47,780.13$12,952$222.72+$124.7KISR
4$183,911$36,586.29$14,086$226.62+$169.8KISR
5$219,621$22,836.04$15,302$230.33+$204.3KISR
6$247,737$12,743.03$16,607$233.85+$231.1KISR
7$271,796$6,717.02$18,007$237.18+$253.8KISR
8$294,265$3,443.62$19,508$240.35+$274.8KISR
9$316,606$1,742.20$21,116$243.35+$295.5KISR
10$339,644$875.92$22,841$246.19+$316.8KISR

ISR vs NOBL: Complete Analysis 2026

ISRStock

Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers. It sells its products to facilities or physician practices that utilize various surgical facilities. Isoray, Inc. was founded in 1998 and is based in Richland, Washington.

Full ISR Calculator →

NOBLETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this ISR vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ISR vs SCHDISR vs JEPIISR vs OISR vs KOISR vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.